Approval · Notice of Compliance 38251 · 2026
IMURAN: Notice of Compliance 38251
Issued September 9, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38251
- Date
- September 9, 2026
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMURAN | Not yet assigned | — |
Medicinal ingredients
- AZATHIOPRINE SODIUM 50 MG per VIAL
- AZATHIOPRINE 50 MG per TAB